Compugroup Medical SE (ETR:COP) has been given a €61.00 ($71.76) price target by HSBC Holdings plc in a report issued on Wednesday. The firm currently has a “buy” rating on the stock.

COP has been the subject of a number of other reports. Deutsche Bank AG set a €60.00 ($70.59) price objective on shares of Compugroup Medical SE and gave the stock a “buy” rating in a research note on Monday, June 26th. Berenberg Bank set a €53.00 ($62.35) price objective on shares of Compugroup Medical SE and gave the stock a “neutral” rating in a research note on Tuesday, September 19th. Baader Bank set a €52.00 ($61.18) price objective on shares of Compugroup Medical SE and gave the stock a “neutral” rating in a research note on Wednesday, September 20th. Finally, Warburg Research set a €52.00 ($61.18) price objective on shares of Compugroup Medical SE and gave the stock a “neutral” rating in a research note on Thursday, August 3rd. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of €55.60 ($65.41).

Shares of Compugroup Medical SE (ETR:COP) opened at 50.019 on Wednesday. The company’s 50-day moving average is €48.60 and its 200-day moving average is €48.13. Compugroup Medical SE has a 12-month low of €36.21 and a 12-month high of €52.80. The firm has a market capitalization of €2.49 billion and a price-to-earnings ratio of 54.666.

TRADEMARK VIOLATION WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/10/18/hsbc-holdings-plc-analysts-give-compugroup-medical-se-cop-a-61-00-price-target.html.

About Compugroup Medical SE

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physicianÂ’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical SE (ETR:COP)

Receive News & Ratings for Compugroup Medical SE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical SE and related companies with MarketBeat.com's FREE daily email newsletter.